Founder and Senior Pathologist, Chestatee Pathology Associates, PC
Member of the Healthcare Council
John Cochran, MD, is the Founder and the Chief Executive Officer of Chestatee Pathology Associates in Atlanta, GA. He is also the Medical Director of two Atlanta-area hospital laboratories and founded the first independent podiatric pathology laboratory in the U.S. Dr. Cochran has consulted on the following entities: Genzyme, Cerner, Immucor, Beckman Coulter (Olympus), Siemens (Bayer/Dade Behring), GenProbe, Cryolife, Quest Diagnostics (Ameripath), LabCorp, Clarient, Biorad, Abbott, Regeneration Technologies, Ortho (J&J), BD (TriPath), Hologic (Cytyc), Qiagen/Digene, Inverness Medical (Biosite), Roche (Ventana), Affymetrix, Dako, Sakura Finetek, Leica, Thermo Fisher, Allscripts (Misys/Sunquest), Sysmex, UpToDate, Ovid, MDConsult (Elsevier), and McKesson. He has experience in anatomic pathology, laboratory medicine, lab automation systems, EMRs, blood banking, information systems, lab regulations, medical billing and cancer drugs. (This is me - Update Profile)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
John Cochran has not published any GLG News Analyses.
| Study Group Name | No. Members |
|---|---|
| Pathologists (US) | 792 |
| Digene-HPV DNA Panel Users (US) | 86 |
| Pricing Experts on Clinical Lab Testing in the U.S. | 57 |
| Users of Triage BNP Test (US) | 35 |
| Digene-HPV DNA Panel Users: Pathologists (US) | 29 |
John Cochran has not participated in any GLG Live Meetings.